| Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis JJ Haringman, DM Gerlag, AH Zwinderman, TJM Smeets, MC Kraan, ... Annals of the rheumatic diseases 64 (6), 834-838, 2005 | 527 | 2005 |
| EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis DM Gerlag, K Raza, LGM Van Baarsen, E Brouwer, CD Buckley, ... Annals of the rheumatic diseases 71 (5), 638-641, 2012 | 507 | 2012 |
| Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response RM Thurlings, K Vos, CA Wijbrandts, AH Zwinderman, DM Gerlag, PP Tak Annals of the rheumatic diseases 67 (7), 917-925, 2008 | 357 | 2008 |
| Inhibitor of nuclear factor κB kinase β is a key regulator of synovial inflammation PP Tak, DM Gerlag, KR Aupperle, DA Van De Geest, M Overbeek, ... Arthritis & Rheumatism 44 (8), 1897-1907, 2001 | 309 | 2001 |
| A randomized controlled trial with an anti‐CCL2 (anti–monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis JJ Haringman, DM Gerlag, TJM Smeets, D Baeten, F Van den Bosch, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2006 | 287 | 2006 |
| Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase MGH Van de Sande, MJH De Hair, C Van Der Leij, PL Klarenbeek, ... Annals of the rheumatic diseases 70 (5), 772-777, 2011 | 272 | 2011 |
| Synovial tissue research: a state-of-the-art review C Orr, E Vieira-Sousa, DL Boyle, MH Buch, CD Buckley, JD Cañete, ... Nature Reviews Rheumatology 13 (8), 463-475, 2017 | 248 | 2017 |
| Modulation of CCR2 in rheumatoid arthritis: a double‐blind, randomized, placebo‐controlled clinical trial CE Vergunst, DM Gerlag, L Lopatinskaya, L Klareskog, MD Smith, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2008 | 236 | 2008 |
| Smoking and overweight determine the likelihood of developing rheumatoid arthritis MJH de Hair, RBM Landewé, MGH van de Sande, D van Schaardenburg, ... Annals of the rheumatic diseases 72 (10), 1654-1658, 2013 | 232 | 2013 |
| Body mass index and clinical response to infliximab in rheumatoid arthritis R Klaasen, CA Wijbrandts, DM Gerlag, PP Tak Arthritis & Rheumatism 63 (2), 359-364, 2011 | 230 | 2011 |
| Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis K Vos, RM Thurlings, CA Wijbrandts, D van Schaardenburg, DM Gerlag, ... Arthritis & Rheumatism 56 (3), 772-778, 2007 | 224 | 2007 |
| Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study DM Gerlag, M Safy, KI Maijer, MW Tang, SW Tas, MJF Starmans-Kool, ... Annals of the rheumatic diseases 78 (2), 179-185, 2019 | 219 | 2019 |
| Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis MJH De Hair, MGH Van De Sande, TH Ramwadhdoebe, M Hansson, ... Arthritis & rheumatology 66 (3), 513-522, 2014 | 186 | 2014 |
| Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss CA Wijbrandts, R Klaasen, MGW Dijkgraaf, DM Gerlag, BLF van Eck-Smit, ... Annals of the rheumatic diseases 68 (3), 373-376, 2009 | 183 | 2009 |
| Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis DM Gerlag, JJ Haringman, TJM Smeets, AH Zwinderman, MC Kraan, ... Arthritis & Rheumatism 50 (12), 3783-3791, 2004 | 182 | 2004 |
| MRP8/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis IY Choi, DM Gerlag, MJ Herenius, RM Thurlings, CA Wijbrandts, D Foell, ... Annals of the rheumatic diseases 74 (3), 499-505, 2015 | 179 | 2015 |
| Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible … LGM van Baarsen, MC Lebre, D van der Coelen, S Aarrass, MW Tang, ... Arthritis research & therapy 16, 1-10, 2014 | 179 | 2014 |
| Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients RM Thurlings, M Boumans, J Tekstra, JA van Roon, K Vos, ... Arthritis & Rheumatism 62 (12), 3607-3614, 2010 | 168 | 2010 |
| Inflamed target tissue provides a specific niche for highly expanded T-cell clones in early human autoimmune disease PL Klarenbeek, MJH De Hair, ME Doorenspleet, BDC Van Schaik, ... Annals of the rheumatic diseases 71 (6), 1088-1093, 2012 | 162 | 2012 |
| Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammation CE Vergunst, DM Gerlag, H Dinant, L Schulz, M Vinkenoog, TJM Smeets, ... Rheumatology 46 (12), 1773-1778, 2007 | 158 | 2007 |
